Treatments · Entity Annotation Prototype (beta)

4articles mentioning treatments

13treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: PTAS ×

PTAS

This treatment is selected. Its supporting articles are shown below.

PTAS4

Articles mentioning PTAS

4 articles · page 1 of 1

Stenting versus medical treatment alone for symptomatic intracranial artery stenosis: a preplanned pooled individual patient data analysis

neurintsurg · abstract · 2025-09-12 · 7 matching annotations

85.6%

PTAS CASSISS SAMMPRIS hyperlipidemia stroke ICAS

…y of TIA, a thorough assessment is warranted before considering PTAS.Trial registration ClinicalTrials.gov Identifier: NCT00576693, …

Preprocedural acute silent ischemic lesions and inhospital stroke after percutaneous transluminal angioplasty and stenting for severe symptomatic intracranial atherosclerotic stenosis

neurintsurg · abstract · 2026-06-03 · 3 matching annotations

86.6%

PTAS tertiary care center ASILs Acute silent ischemic lesions (ASILs)Preprocedural ASILs severe intracranial stenosis severe sICAS

…SILs were independently associated with inhospital stroke after PTAS in patients with severe sICAS. Incorporation of ASIL status int…

Effects of different endovascular treatments on cerebral perfusion changes and stroke recurrence in patients with intracranial atherosclerosis

neurintsurg · abstract · 2025-11-18 · 2 matching annotations

79.4%

percutaneous transluminal balloon angioplasty PTBA PTAS percutaneous transluminal angioplasty with stenting ICAD PTBA

…ts with refractory intracranial atherosclerotic disease (ICAD), percutaneous transluminal balloon angioplasty (PTBA) is less complex but typically results in higher postproc…

Impact of lesion calcification and hardness on periprocedural brain ischemia in patients with intracranial atherosclerotic disease undergoing angioplasty and stenting

neurintsurg · abstract · 2026-05-14 · 1 matching annotations

76.6%

PTAS PBILs

…meter were identified as potential risk factors for PBILs after PTAS in patients with medically refractory ICAS.…